Publications by authors named "A M B van den Bruele"
Bilateral risk-reducing mastectomy (BRRM) is the surgical removal of both breasts to reduce the risk of cancer. In this Society of Surgical Oncology position statement, we review the literature addressing the indications, outcomes, and risks of BRRM to update the society's 2017 statement. We held a virtual meeting to outline key topics and conducted a literature search using PubMed to identify relevant articles.
View Article and Find Full Text PDFBackground: Axillary management after neoadjuvant chemotherapy (NAC) is evolving but axillary lymph node dissection (ALND) remains the standard of care for patients with residual nodal disease. The results of the Alliance A011202 trial evaluating the oncologic safety of ALND omission in this cohort are pending but we hypothesize that ALND omission is already increasing.
Methods: The National Cancer Database was queried to identify patients diagnosed with cT1-3N1M0 breast cancer who underwent NAC and had residual nodal disease (ypN1mi-2) from 2012 to 2021.
Background: Older breast cancer patients represent a heterogeneous population. Studies demonstrate that sentinel lymph node biopsy (SLNB) omission may be appropriate in some clinical scenarios, yet patients with triple-negative breast cancer (TNBC) are often excluded from these studies. This study evaluated differences in treatment and survival for older patients with TNBC based on SLNB receipt and result.
View Article and Find Full Text PDFArticle Synopsis
- Patients with inflammatory breast cancer (IBC) experience worse overall survival compared to non-IBC patients, despite similar treatment approaches.
- The study analyzed data from 38,390 women with stage III breast cancer, showing that IBC patients had lower pathologic complete response (pCR) rates (20.7% vs. 23.3% for non-IBC), and higher 5-year mortality for those achieving pCR (16.4% vs. 9.1%).
- The findings suggest that even when IBC patients achieve pCR, their survival outcomes remain poorer than those of non-IBC patients, indicating the need for more effective treatment strategies for IBC.